Financial Analysis: Beauty Health (NASDAQ:SKIN) vs. Alpha Tau Medical (NASDAQ:DRTS)


Alpha Tau Medical (NASDAQ:DRTS – Get Rating) and Beauty Health (NASDAQ:SKIN – Get Rating) are both small-cap medical companies, but which is the best investment? We’ll compare the two companies based on their dividend strength, profitability, risk, earnings, analyst recommendations, institutional ownership and valuation.

Valuation and benefits

This table compares gross revenue, earnings per share (EPS), and valuation of Alpha Tau Medical and Beauty Health.

Gross revenue Price/sales ratio Net revenue Earnings per share Price/earnings ratio
Alpha Tau Medical N / A N / A -$27.27 million N / A N / A
Beauty and health $260.09 million 7.42 -$375.11 million ($3.40) -3.79

Alpha Tau Medical has higher revenue, but lower revenue than Beauty Health.

Insider and Institutional Ownership

81.9% of Alpha Tau Medical shares are held by institutional investors. By comparison, 72.0% of Beauty Health shares are held by institutional investors. 34.3% of Beauty Health shares are held by insiders of the company. Strong institutional ownership indicates that large money managers, endowments, and hedge funds believe a stock is poised for long-term growth.

Analyst Notes

This is a breakdown of the current ratings and recommendations for Alpha Tau Medical and Beauty Health, as reported by MarketBeat.com.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Alpha Tau Medical 0 0 3 0 3.00
Beauty and health 0 1 8 0 2.89

Alpha Tau Medical currently has a consensus target price of $20.00, indicating a potential upside of 94.36%. Beauty Health has a consensus target price of $24.75, indicating a potential upside of 91.86%. Given Alpha Tau Medical’s stronger consensus rating and higher possible upside, analysts clearly believe that Alpha Tau Medical is more favorable than Beauty Health.

Profitability

This table compares the net margins, return on equity and return on assets of Alpha Tau Medical and Beauty Health.

Net margins Return on equity return on assets
Alpha Tau Medical N / A -412.61% -23.16%
Beauty and health -117.84% -0.01% N / A

Risk and Volatility

Alpha Tau Medical has a beta of 0.32, which means its stock price is 68% less volatile than the S&P 500. Comparatively, Beauty Health has a beta of 1.67, which means its stock price is 67 % more volatile than the S&P 500.

Summary

Beauty Health beats Alpha Tau Medical on 6 out of 11 factors compared between the two stocks.

About Alpha Tau Medical

(Get a rating)

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, is engaged in the research, development and commercialization of alpha emitter diffusion radiation therapy (Alpha DaRT) for the treatment of solid cancer in Israel and the United States. United States. Its Alpha-DaRT technology used in clinical trials for skin, mouth, pancreatic and breast cancers; and preclinical studies for liver cell carcinoma, glioblastoma multiforme, lung cancer and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

About Beauty Health

(Get an evaluation)

The Beauty Health Company designs, develops, manufactures, markets and sells aesthetic technology and products worldwide. The company’s flagship product includes skin-enhancing HydraFacial to cleanse, peel, exfoliate, extract, infuse and hydrate skin with proprietary solutions and serums. Its products also include Syndeo, a HydraFacial delivery system designed to elevate every part of treatment and connect providers with consumer preferences to create a more personalized experience; HydraFacial Nation App, an application that allows consumers to learn more about their skin health, discover treatment options and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is based in Long Beach, California.



Get news and reviews for Alpha Tau Medical Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Alpha Tau Medical and related companies with MarketBeat.com’s FREE daily newsletter.

.

Leave a Comment